nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—ACHE—Physostigmine—glaucoma	0.127	0.154	CbGbCtD
Procainamide—ACHE—Echothiophate—glaucoma	0.127	0.154	CbGbCtD
Procainamide—ACHE—Dipivefrin—glaucoma	0.0768	0.0935	CbGbCtD
Procainamide—BCHE—Physostigmine—glaucoma	0.0764	0.0929	CbGbCtD
Procainamide—BCHE—Echothiophate—glaucoma	0.0764	0.0929	CbGbCtD
Procainamide—SLC22A1—Latanoprost—glaucoma	0.0538	0.0655	CbGbCtD
Procainamide—BCHE—Dipivefrin—glaucoma	0.0463	0.0563	CbGbCtD
Procainamide—SLC22A4—Clonidine—glaucoma	0.0425	0.0518	CbGbCtD
Procainamide—SLC22A3—Clonidine—glaucoma	0.0387	0.0471	CbGbCtD
Procainamide—CHRM2—Carbachol—glaucoma	0.0347	0.0423	CbGbCtD
Procainamide—CHRM2—Pilocarpine—glaucoma	0.0323	0.0393	CbGbCtD
Procainamide—SLC22A5—Clonidine—glaucoma	0.024	0.0292	CbGbCtD
Procainamide—SLC22A1—Clonidine—glaucoma	0.0199	0.0242	CbGbCtD
Procainamide—CYP2D6—Carteolol—glaucoma	0.0155	0.0189	CbGbCtD
Procainamide—CYP2D6—Betaxolol—glaucoma	0.0105	0.0128	CbGbCtD
Procainamide—CYP2D6—Methazolamide—glaucoma	0.00795	0.00967	CbGbCtD
Procainamide—CYP2D6—Timolol—glaucoma	0.00676	0.00822	CbGbCtD
Procainamide—CYP2D6—Clonidine—glaucoma	0.00575	0.00699	CbGbCtD
Procainamide—Sunitinib—MYLK—glaucoma	0.00208	0.417	CrCbGaD
Procainamide—Sunitinib—TBK1—glaucoma	0.00208	0.417	CrCbGaD
Procainamide—Sunitinib—NTRK1—glaucoma	0.000829	0.166	CrCbGaD
Procainamide—Dysgeusia—Acetazolamide—glaucoma	0.00043	0.00303	CcSEcCtD
Procainamide—Urticaria—Levobunolol—glaucoma	0.00043	0.00303	CcSEcCtD
Procainamide—Psychotic disorder—Betaxolol—glaucoma	0.000429	0.00302	CcSEcCtD
Procainamide—Cardiac disorder—Travoprost—glaucoma	0.000427	0.00301	CcSEcCtD
Procainamide—Feeling abnormal—Methazolamide—glaucoma	0.000427	0.00301	CcSEcCtD
Procainamide—Cardiac disorder—Brinzolamide—glaucoma	0.000422	0.00298	CcSEcCtD
Procainamide—Hypersensitivity—Carteolol—glaucoma	0.000422	0.00297	CcSEcCtD
Procainamide—Myalgia—Apraclonidine—glaucoma	0.000418	0.00295	CcSEcCtD
Procainamide—Discomfort—Apraclonidine—glaucoma	0.000413	0.00291	CcSEcCtD
Procainamide—Dysgeusia—Brimonidine—glaucoma	0.000413	0.00291	CcSEcCtD
Procainamide—Urticaria—Methazolamide—glaucoma	0.000412	0.0029	CcSEcCtD
Procainamide—Asthenia—Carteolol—glaucoma	0.000411	0.00289	CcSEcCtD
Procainamide—Body temperature increased—Methazolamide—glaucoma	0.000409	0.00289	CcSEcCtD
Procainamide—Dizziness—Metipranolol—glaucoma	0.000408	0.00288	CcSEcCtD
Procainamide—Ill-defined disorder—Acetazolamide—glaucoma	0.000408	0.00287	CcSEcCtD
Procainamide—Flushing—Pilocarpine—glaucoma	0.000406	0.00286	CcSEcCtD
Procainamide—Asthenia—Diclofenamide—glaucoma	0.000404	0.00285	CcSEcCtD
Procainamide—Hypersensitivity—Levobunolol—glaucoma	0.000398	0.00281	CcSEcCtD
Procainamide—Pruritus—Diclofenamide—glaucoma	0.000398	0.00281	CcSEcCtD
Procainamide—Malaise—Acetazolamide—glaucoma	0.000396	0.00279	CcSEcCtD
Procainamide—Dysgeusia—Dorzolamide—glaucoma	0.000394	0.00278	CcSEcCtD
Procainamide—Dysgeusia—Travoprost—glaucoma	0.000393	0.00277	CcSEcCtD
Procainamide—Chills—Pilocarpine—glaucoma	0.000392	0.00277	CcSEcCtD
Procainamide—Asthenia—Levobunolol—glaucoma	0.000388	0.00274	CcSEcCtD
Procainamide—Depression—Clonidine—glaucoma	0.000388	0.00273	CcSEcCtD
Procainamide—Dysgeusia—Brinzolamide—glaucoma	0.000388	0.00273	CcSEcCtD
Procainamide—Pruritus—Levobunolol—glaucoma	0.000383	0.0027	CcSEcCtD
Procainamide—Convulsion—Acetazolamide—glaucoma	0.000381	0.00268	CcSEcCtD
Procainamide—Dizziness—Carteolol—glaucoma	0.000378	0.00267	CcSEcCtD
Procainamide—Diarrhoea—Carbachol—glaucoma	0.000376	0.00265	CcSEcCtD
Procainamide—Dysgeusia—Pilocarpine—glaucoma	0.000373	0.00263	CcSEcCtD
Procainamide—Ill-defined disorder—Travoprost—glaucoma	0.000372	0.00262	CcSEcCtD
Procainamide—Dizziness—Diclofenamide—glaucoma	0.000372	0.00262	CcSEcCtD
Procainamide—Asthenia—Methazolamide—glaucoma	0.000372	0.00262	CcSEcCtD
Procainamide—Diarrhoea—Levobunolol—glaucoma	0.00037	0.00261	CcSEcCtD
Procainamide—Discomfort—Acetazolamide—glaucoma	0.00037	0.00261	CcSEcCtD
Procainamide—Angioedema—Dorzolamide—glaucoma	0.000368	0.00259	CcSEcCtD
Procainamide—Cardiac failure—Timolol—glaucoma	0.000368	0.00259	CcSEcCtD
Procainamide—Ill-defined disorder—Brinzolamide—glaucoma	0.000367	0.00259	CcSEcCtD
Procainamide—Nausea—Metipranolol—glaucoma	0.000367	0.00259	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000365	0.00257	CcSEcCtD
Procainamide—Dizziness—Carbachol—glaucoma	0.000363	0.00256	CcSEcCtD
Procainamide—Malaise—Travoprost—glaucoma	0.000362	0.00255	CcSEcCtD
Procainamide—Confusional state—Acetazolamide—glaucoma	0.000362	0.00255	CcSEcCtD
Procainamide—Arthralgia—Brimonidine—glaucoma	0.000359	0.00253	CcSEcCtD
Procainamide—Myalgia—Brimonidine—glaucoma	0.000359	0.00253	CcSEcCtD
Procainamide—Vomiting—Diclofenamide—glaucoma	0.000358	0.00252	CcSEcCtD
Procainamide—Dizziness—Levobunolol—glaucoma	0.000358	0.00252	CcSEcCtD
Procainamide—Malaise—Brinzolamide—glaucoma	0.000357	0.00252	CcSEcCtD
Procainamide—Bradycardia—Clonidine—glaucoma	0.000355	0.00251	CcSEcCtD
Procainamide—Pruritus—Latanoprost—glaucoma	0.000355	0.0025	CcSEcCtD
Procainamide—Discomfort—Brimonidine—glaucoma	0.000355	0.0025	CcSEcCtD
Procainamide—Diarrhoea—Methazolamide—glaucoma	0.000354	0.0025	CcSEcCtD
Procainamide—Shock—Acetazolamide—glaucoma	0.000353	0.00249	CcSEcCtD
Procainamide—Thrombocytopenia—Acetazolamide—glaucoma	0.000351	0.00248	CcSEcCtD
Procainamide—Vomiting—Carbachol—glaucoma	0.000349	0.00246	CcSEcCtD
Procainamide—Hallucination—Clonidine—glaucoma	0.000347	0.00245	CcSEcCtD
Procainamide—Arthralgia—Dorzolamide—glaucoma	0.000343	0.00242	CcSEcCtD
Procainamide—Arthralgia—Travoprost—glaucoma	0.000341	0.00241	CcSEcCtD
Procainamide—Myalgia—Travoprost—glaucoma	0.000341	0.00241	CcSEcCtD
Procainamide—Cardiac arrest—Timolol—glaucoma	0.000341	0.00241	CcSEcCtD
Procainamide—Nausea—Carteolol—glaucoma	0.00034	0.0024	CcSEcCtD
Procainamide—Discomfort—Dorzolamide—glaucoma	0.000339	0.00239	CcSEcCtD
Procainamide—Shock—Brimonidine—glaucoma	0.000339	0.00239	CcSEcCtD
Procainamide—Depression—Betaxolol—glaucoma	0.000338	0.00238	CcSEcCtD
Procainamide—Discomfort—Travoprost—glaucoma	0.000337	0.00238	CcSEcCtD
Procainamide—Arthralgia—Brinzolamide—glaucoma	0.000337	0.00238	CcSEcCtD
Procainamide—Myalgia—Brinzolamide—glaucoma	0.000337	0.00238	CcSEcCtD
Procainamide—Nausea—Diclofenamide—glaucoma	0.000334	0.00236	CcSEcCtD
Procainamide—Discomfort—Brinzolamide—glaucoma	0.000333	0.00235	CcSEcCtD
Procainamide—Dizziness—Latanoprost—glaucoma	0.000332	0.00234	CcSEcCtD
Procainamide—Confusional state—Dorzolamide—glaucoma	0.000331	0.00234	CcSEcCtD
Procainamide—Feeling abnormal—Apraclonidine—glaucoma	0.00033	0.00233	CcSEcCtD
Procainamide—Vomiting—Methazolamide—glaucoma	0.000329	0.00232	CcSEcCtD
Procainamide—Gastrointestinal pain—Apraclonidine—glaucoma	0.000328	0.00231	CcSEcCtD
Procainamide—Abdominal pain upper—Timolol—glaucoma	0.000328	0.00231	CcSEcCtD
Procainamide—Nausea—Carbachol—glaucoma	0.000326	0.0023	CcSEcCtD
Procainamide—Cardiac disorder—Clonidine—glaucoma	0.000324	0.00228	CcSEcCtD
Procainamide—Myalgia—Pilocarpine—glaucoma	0.000324	0.00228	CcSEcCtD
Procainamide—Arthralgia—Pilocarpine—glaucoma	0.000324	0.00228	CcSEcCtD
Procainamide—Shock—Dorzolamide—glaucoma	0.000323	0.00228	CcSEcCtD
Procainamide—Hypotension—Brimonidine—glaucoma	0.000322	0.00227	CcSEcCtD
Procainamide—Nausea—Levobunolol—glaucoma	0.000321	0.00226	CcSEcCtD
Procainamide—Discomfort—Pilocarpine—glaucoma	0.00032	0.00226	CcSEcCtD
Procainamide—Abdominal pain—Apraclonidine—glaucoma	0.000317	0.00223	CcSEcCtD
Procainamide—Agranulocytosis—Betaxolol—glaucoma	0.000316	0.00223	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000314	0.00221	CcSEcCtD
Procainamide—Anorexia—Dorzolamide—glaucoma	0.000313	0.00221	CcSEcCtD
Procainamide—Confusional state—Pilocarpine—glaucoma	0.000313	0.00221	CcSEcCtD
Procainamide—Decreased appetite—Acetazolamide—glaucoma	0.000312	0.0022	CcSEcCtD
Procainamide—Bradycardia—Betaxolol—glaucoma	0.000309	0.00218	CcSEcCtD
Procainamide—Nausea—Methazolamide—glaucoma	0.000308	0.00217	CcSEcCtD
Procainamide—Hypotension—Dorzolamide—glaucoma	0.000307	0.00217	CcSEcCtD
Procainamide—Hypotension—Travoprost—glaucoma	0.000306	0.00216	CcSEcCtD
Procainamide—Shock—Pilocarpine—glaucoma	0.000306	0.00215	CcSEcCtD
Procainamide—Thrombocytopenia—Pilocarpine—glaucoma	0.000304	0.00214	CcSEcCtD
Procainamide—Hallucination—Betaxolol—glaucoma	0.000302	0.00213	CcSEcCtD
Procainamide—Hypotension—Brinzolamide—glaucoma	0.000302	0.00213	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000299	0.00211	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Travoprost—glaucoma	0.000298	0.0021	CcSEcCtD
Procainamide—Anorexia—Pilocarpine—glaucoma	0.000296	0.00209	CcSEcCtD
Procainamide—Feeling abnormal—Acetazolamide—glaucoma	0.000295	0.00208	CcSEcCtD
Procainamide—Hypersensitivity—Apraclonidine—glaucoma	0.000295	0.00208	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000294	0.00208	CcSEcCtD
Procainamide—Hypotension—Pilocarpine—glaucoma	0.00029	0.00205	CcSEcCtD
Procainamide—Asthenia—Apraclonidine—glaucoma	0.000288	0.00203	CcSEcCtD
Procainamide—Decreased appetite—Dorzolamide—glaucoma	0.000286	0.00201	CcSEcCtD
Procainamide—Urticaria—Acetazolamide—glaucoma	0.000285	0.00201	CcSEcCtD
Procainamide—Pruritus—Apraclonidine—glaucoma	0.000284	0.002	CcSEcCtD
Procainamide—Body temperature increased—Acetazolamide—glaucoma	0.000283	0.002	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000283	0.00199	CcSEcCtD
Procainamide—Cardiac disorder—Betaxolol—glaucoma	0.000282	0.00199	CcSEcCtD
Procainamide—Flushing—Betaxolol—glaucoma	0.000282	0.00199	CcSEcCtD
Procainamide—Ill-defined disorder—Clonidine—glaucoma	0.000282	0.00199	CcSEcCtD
Procainamide—Decreased appetite—Brinzolamide—glaucoma	0.000281	0.00198	CcSEcCtD
Procainamide—Asthenia—Bimatoprost—glaucoma	0.000279	0.00197	CcSEcCtD
Procainamide—Angioedema—Clonidine—glaucoma	0.000278	0.00196	CcSEcCtD
Procainamide—Depression—Timolol—glaucoma	0.000276	0.00194	CcSEcCtD
Procainamide—Pruritus—Bimatoprost—glaucoma	0.000275	0.00194	CcSEcCtD
Procainamide—Diarrhoea—Apraclonidine—glaucoma	0.000274	0.00193	CcSEcCtD
Procainamide—Malaise—Clonidine—glaucoma	0.000274	0.00193	CcSEcCtD
Procainamide—Chills—Betaxolol—glaucoma	0.000273	0.00192	CcSEcCtD
Procainamide—Feeling abnormal—Dorzolamide—glaucoma	0.000271	0.00191	CcSEcCtD
Procainamide—Decreased appetite—Pilocarpine—glaucoma	0.00027	0.0019	CcSEcCtD
Procainamide—Feeling abnormal—Travoprost—glaucoma	0.00027	0.0019	CcSEcCtD
Procainamide—Gastrointestinal pain—Dorzolamide—glaucoma	0.000269	0.00189	CcSEcCtD
Procainamide—Gastrointestinal pain—Travoprost—glaucoma	0.000268	0.00189	CcSEcCtD
Procainamide—Feeling abnormal—Brinzolamide—glaucoma	0.000266	0.00188	CcSEcCtD
Procainamide—Dizziness—Apraclonidine—glaucoma	0.000265	0.00187	CcSEcCtD
Procainamide—Urticaria—Dorzolamide—glaucoma	0.000261	0.00184	CcSEcCtD
Procainamide—Body temperature increased—Dorzolamide—glaucoma	0.00026	0.00183	CcSEcCtD
Procainamide—Abdominal pain—Dorzolamide—glaucoma	0.00026	0.00183	CcSEcCtD
Procainamide—Dysgeusia—Betaxolol—glaucoma	0.000259	0.00183	CcSEcCtD
Procainamide—Arthralgia—Clonidine—glaucoma	0.000259	0.00182	CcSEcCtD
Procainamide—Abdominal pain—Travoprost—glaucoma	0.000259	0.00182	CcSEcCtD
Procainamide—Agranulocytosis—Timolol—glaucoma	0.000258	0.00182	CcSEcCtD
Procainamide—Asthenia—Acetazolamide—glaucoma	0.000257	0.00181	CcSEcCtD
Procainamide—Dizziness—Bimatoprost—glaucoma	0.000257	0.00181	CcSEcCtD
Procainamide—Urticaria—Brinzolamide—glaucoma	0.000257	0.00181	CcSEcCtD
Procainamide—Feeling abnormal—Pilocarpine—glaucoma	0.000256	0.0018	CcSEcCtD
Procainamide—Discomfort—Clonidine—glaucoma	0.000256	0.0018	CcSEcCtD
Procainamide—Vomiting—Apraclonidine—glaucoma	0.000255	0.0018	CcSEcCtD
Procainamide—Gastrointestinal pain—Pilocarpine—glaucoma	0.000254	0.00179	CcSEcCtD
Procainamide—Hypersensitivity—Brimonidine—glaucoma	0.000254	0.00179	CcSEcCtD
Procainamide—Bradycardia—Timolol—glaucoma	0.000253	0.00178	CcSEcCtD
Procainamide—Confusional state—Clonidine—glaucoma	0.00025	0.00176	CcSEcCtD
Procainamide—Hallucination—Timolol—glaucoma	0.000247	0.00174	CcSEcCtD
Procainamide—Asthenia—Brimonidine—glaucoma	0.000247	0.00174	CcSEcCtD
Procainamide—Abdominal pain—Pilocarpine—glaucoma	0.000246	0.00173	CcSEcCtD
Procainamide—Body temperature increased—Pilocarpine—glaucoma	0.000246	0.00173	CcSEcCtD
Procainamide—Ill-defined disorder—Betaxolol—glaucoma	0.000245	0.00173	CcSEcCtD
Procainamide—Diarrhoea—Acetazolamide—glaucoma	0.000245	0.00173	CcSEcCtD
Procainamide—Shock—Clonidine—glaucoma	0.000244	0.00172	CcSEcCtD
Procainamide—Pruritus—Brimonidine—glaucoma	0.000243	0.00172	CcSEcCtD
Procainamide—Thrombocytopenia—Clonidine—glaucoma	0.000243	0.00171	CcSEcCtD
Procainamide—Hypersensitivity—Dorzolamide—glaucoma	0.000242	0.00171	CcSEcCtD
Procainamide—Hypersensitivity—Travoprost—glaucoma	0.000241	0.0017	CcSEcCtD
Procainamide—Malaise—Betaxolol—glaucoma	0.000239	0.00168	CcSEcCtD
Procainamide—Nausea—Apraclonidine—glaucoma	0.000238	0.00168	CcSEcCtD
Procainamide—Hypersensitivity—Brinzolamide—glaucoma	0.000238	0.00168	CcSEcCtD
Procainamide—Dizziness—Acetazolamide—glaucoma	0.000237	0.00167	CcSEcCtD
Procainamide—Anorexia—Clonidine—glaucoma	0.000236	0.00167	CcSEcCtD
Procainamide—Asthenia—Dorzolamide—glaucoma	0.000236	0.00166	CcSEcCtD
Procainamide—Asthenia—Travoprost—glaucoma	0.000235	0.00166	CcSEcCtD
Procainamide—Pruritus—Dorzolamide—glaucoma	0.000233	0.00164	CcSEcCtD
Procainamide—Asthenia—Brinzolamide—glaucoma	0.000232	0.00163	CcSEcCtD
Procainamide—Hypotension—Clonidine—glaucoma	0.000232	0.00163	CcSEcCtD
Procainamide—Pruritus—Travoprost—glaucoma	0.000232	0.00163	CcSEcCtD
Procainamide—Nausea—Bimatoprost—glaucoma	0.000231	0.00163	CcSEcCtD
Procainamide—Cardiac disorder—Timolol—glaucoma	0.00023	0.00162	CcSEcCtD
Procainamide—Hypersensitivity—Pilocarpine—glaucoma	0.000229	0.00161	CcSEcCtD
Procainamide—Pruritus—Brinzolamide—glaucoma	0.000229	0.00161	CcSEcCtD
Procainamide—Vomiting—Acetazolamide—glaucoma	0.000228	0.00161	CcSEcCtD
Procainamide—Dizziness—Brimonidine—glaucoma	0.000228	0.0016	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Clonidine—glaucoma	0.000226	0.00159	CcSEcCtD
Procainamide—Arthralgia—Betaxolol—glaucoma	0.000225	0.00159	CcSEcCtD
Procainamide—Myalgia—Betaxolol—glaucoma	0.000225	0.00159	CcSEcCtD
Procainamide—Diarrhoea—Dorzolamide—glaucoma	0.000225	0.00159	CcSEcCtD
Procainamide—Diarrhoea—Travoprost—glaucoma	0.000224	0.00158	CcSEcCtD
Procainamide—Asthenia—Pilocarpine—glaucoma	0.000223	0.00157	CcSEcCtD
Procainamide—Discomfort—Betaxolol—glaucoma	0.000223	0.00157	CcSEcCtD
Procainamide—Diarrhoea—Brinzolamide—glaucoma	0.000221	0.00156	CcSEcCtD
Procainamide—Pruritus—Pilocarpine—glaucoma	0.00022	0.00155	CcSEcCtD
Procainamide—Confusional state—Betaxolol—glaucoma	0.000218	0.00153	CcSEcCtD
Procainamide—Dizziness—Dorzolamide—glaucoma	0.000217	0.00153	CcSEcCtD
Procainamide—Dizziness—Travoprost—glaucoma	0.000216	0.00153	CcSEcCtD
Procainamide—Decreased appetite—Clonidine—glaucoma	0.000216	0.00152	CcSEcCtD
Procainamide—Dizziness—Brinzolamide—glaucoma	0.000214	0.00151	CcSEcCtD
Procainamide—Nausea—Acetazolamide—glaucoma	0.000213	0.0015	CcSEcCtD
Procainamide—Diarrhoea—Pilocarpine—glaucoma	0.000212	0.0015	CcSEcCtD
Procainamide—Shock—Betaxolol—glaucoma	0.000212	0.0015	CcSEcCtD
Procainamide—Dysgeusia—Timolol—glaucoma	0.000212	0.00149	CcSEcCtD
Procainamide—Thrombocytopenia—Betaxolol—glaucoma	0.000211	0.00149	CcSEcCtD
Procainamide—Vomiting—Dorzolamide—glaucoma	0.000209	0.00147	CcSEcCtD
Procainamide—Anorexia—Betaxolol—glaucoma	0.000206	0.00145	CcSEcCtD
Procainamide—Vomiting—Brinzolamide—glaucoma	0.000205	0.00145	CcSEcCtD
Procainamide—Dizziness—Pilocarpine—glaucoma	0.000205	0.00145	CcSEcCtD
Procainamide—Nausea—Brimonidine—glaucoma	0.000204	0.00144	CcSEcCtD
Procainamide—Feeling abnormal—Clonidine—glaucoma	0.000204	0.00144	CcSEcCtD
Procainamide—Gastrointestinal pain—Clonidine—glaucoma	0.000203	0.00143	CcSEcCtD
Procainamide—Hypotension—Betaxolol—glaucoma	0.000202	0.00142	CcSEcCtD
Procainamide—Angioedema—Timolol—glaucoma	0.000197	0.00139	CcSEcCtD
Procainamide—Vomiting—Pilocarpine—glaucoma	0.000197	0.00139	CcSEcCtD
Procainamide—Urticaria—Clonidine—glaucoma	0.000197	0.00139	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000197	0.00139	CcSEcCtD
Procainamide—Abdominal pain—Clonidine—glaucoma	0.000196	0.00138	CcSEcCtD
Procainamide—Body temperature increased—Clonidine—glaucoma	0.000196	0.00138	CcSEcCtD
Procainamide—Nausea—Dorzolamide—glaucoma	0.000195	0.00138	CcSEcCtD
Procainamide—Nausea—Travoprost—glaucoma	0.000194	0.00137	CcSEcCtD
Procainamide—Nausea—Brinzolamide—glaucoma	0.000192	0.00135	CcSEcCtD
Procainamide—Decreased appetite—Betaxolol—glaucoma	0.000188	0.00132	CcSEcCtD
Procainamide—Nausea—Pilocarpine—glaucoma	0.000184	0.0013	CcSEcCtD
Procainamide—Myalgia—Timolol—glaucoma	0.000184	0.0013	CcSEcCtD
Procainamide—Arthralgia—Timolol—glaucoma	0.000184	0.0013	CcSEcCtD
Procainamide—Hypersensitivity—Clonidine—glaucoma	0.000183	0.00129	CcSEcCtD
Procainamide—Discomfort—Timolol—glaucoma	0.000182	0.00128	CcSEcCtD
Procainamide—Asthenia—Clonidine—glaucoma	0.000178	0.00125	CcSEcCtD
Procainamide—Feeling abnormal—Betaxolol—glaucoma	0.000178	0.00125	CcSEcCtD
Procainamide—Confusional state—Timolol—glaucoma	0.000178	0.00125	CcSEcCtD
Procainamide—Pruritus—Clonidine—glaucoma	0.000175	0.00124	CcSEcCtD
Procainamide—Shock—Timolol—glaucoma	0.000174	0.00122	CcSEcCtD
Procainamide—Urticaria—Betaxolol—glaucoma	0.000172	0.00121	CcSEcCtD
Procainamide—Body temperature increased—Betaxolol—glaucoma	0.000171	0.0012	CcSEcCtD
Procainamide—Diarrhoea—Clonidine—glaucoma	0.00017	0.0012	CcSEcCtD
Procainamide—Anorexia—Timolol—glaucoma	0.000168	0.00119	CcSEcCtD
Procainamide—Hypotension—Timolol—glaucoma	0.000165	0.00116	CcSEcCtD
Procainamide—Dizziness—Clonidine—glaucoma	0.000164	0.00116	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Timolol—glaucoma	0.000161	0.00113	CcSEcCtD
Procainamide—Hypersensitivity—Betaxolol—glaucoma	0.000159	0.00112	CcSEcCtD
Procainamide—Vomiting—Clonidine—glaucoma	0.000158	0.00111	CcSEcCtD
Procainamide—Asthenia—Betaxolol—glaucoma	0.000155	0.00109	CcSEcCtD
Procainamide—Decreased appetite—Timolol—glaucoma	0.000153	0.00108	CcSEcCtD
Procainamide—Pruritus—Betaxolol—glaucoma	0.000153	0.00108	CcSEcCtD
Procainamide—Diarrhoea—Betaxolol—glaucoma	0.000148	0.00104	CcSEcCtD
Procainamide—Nausea—Clonidine—glaucoma	0.000147	0.00104	CcSEcCtD
Procainamide—Feeling abnormal—Timolol—glaucoma	0.000145	0.00102	CcSEcCtD
Procainamide—Gastrointestinal pain—Timolol—glaucoma	0.000144	0.00102	CcSEcCtD
Procainamide—Dizziness—Betaxolol—glaucoma	0.000143	0.00101	CcSEcCtD
Procainamide—Urticaria—Timolol—glaucoma	0.00014	0.000988	CcSEcCtD
Procainamide—Abdominal pain—Timolol—glaucoma	0.000139	0.000983	CcSEcCtD
Procainamide—Body temperature increased—Timolol—glaucoma	0.000139	0.000983	CcSEcCtD
Procainamide—Vomiting—Betaxolol—glaucoma	0.000137	0.000968	CcSEcCtD
Procainamide—Hypersensitivity—Timolol—glaucoma	0.00013	0.000916	CcSEcCtD
Procainamide—Nausea—Betaxolol—glaucoma	0.000128	0.000904	CcSEcCtD
Procainamide—Asthenia—Timolol—glaucoma	0.000127	0.000892	CcSEcCtD
Procainamide—Pruritus—Timolol—glaucoma	0.000125	0.00088	CcSEcCtD
Procainamide—Diarrhoea—Timolol—glaucoma	0.000121	0.000851	CcSEcCtD
Procainamide—Dizziness—Timolol—glaucoma	0.000117	0.000822	CcSEcCtD
Procainamide—Vomiting—Timolol—glaucoma	0.000112	0.000791	CcSEcCtD
Procainamide—Nausea—Timolol—glaucoma	0.000105	0.000739	CcSEcCtD
Procainamide—ACHE—Metabolism of proteins—CTSA—glaucoma	6.02e-05	0.00191	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.98e-05	0.0019	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CA5A—glaucoma	5.86e-05	0.00186	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NARFL—glaucoma	5.86e-05	0.00186	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—SLC6A1—glaucoma	5.82e-05	0.00185	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—PTGFR—glaucoma	5.82e-05	0.00185	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.78e-05	0.00184	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.76e-05	0.00183	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.75e-05	0.00182	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	5.74e-05	0.00182	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—MMP9—glaucoma	5.7e-05	0.00181	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—ACE2—glaucoma	5.54e-05	0.00176	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—SLC6A1—glaucoma	5.43e-05	0.00172	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—MMP2—glaucoma	5.41e-05	0.00172	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CTSA—glaucoma	5.37e-05	0.0017	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CA5A—glaucoma	5.23e-05	0.00166	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NARFL—glaucoma	5.23e-05	0.00166	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—VEGFA—glaucoma	5.12e-05	0.00162	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—MMP9—glaucoma	5.08e-05	0.00161	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—PAX6—glaucoma	5.05e-05	0.0016	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—MMP2—glaucoma	5e-05	0.00159	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.99e-05	0.00158	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.98e-05	0.00158	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—ACE2—glaucoma	4.94e-05	0.00157	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	4.92e-05	0.00156	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NARFL—glaucoma	4.87e-05	0.00155	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CA5A—glaucoma	4.87e-05	0.00155	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MMP2—glaucoma	4.82e-05	0.00153	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—MMP2—glaucoma	4.78e-05	0.00152	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—MMP9—glaucoma	4.65e-05	0.00147	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MMP2—glaucoma	4.59e-05	0.00146	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MMP2—glaucoma	4.59e-05	0.00146	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—BDNF—glaucoma	4.59e-05	0.00146	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—VEGFA—glaucoma	4.56e-05	0.00145	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MMP2—glaucoma	4.43e-05	0.00141	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MMP2—glaucoma	4.43e-05	0.00141	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MMP2—glaucoma	4.41e-05	0.0014	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL1A—glaucoma	4.41e-05	0.0014	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.28e-05	0.00136	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.21e-05	0.00133	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—VEGFA—glaucoma	4.17e-05	0.00132	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	4.07e-05	0.00129	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CA1—glaucoma	4.07e-05	0.00129	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—MMP9—glaucoma	4.07e-05	0.00129	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	4.05e-05	0.00129	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.99e-05	0.00127	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CTSA—glaucoma	3.94e-05	0.00125	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—GSTT1—glaucoma	3.84e-05	0.00122	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.77e-05	0.0012	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—MMP9—glaucoma	3.76e-05	0.00119	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CA2—glaucoma	3.72e-05	0.00118	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—VEGFA—glaucoma	3.65e-05	0.00116	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OPN4—glaucoma	3.65e-05	0.00116	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MMP9—glaucoma	3.63e-05	0.00115	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—MMP9—glaucoma	3.59e-05	0.00114	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MMP2—glaucoma	3.57e-05	0.00113	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	3.53e-05	0.00112	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MMP9—glaucoma	3.45e-05	0.0011	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MMP9—glaucoma	3.45e-05	0.0011	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MMP2—glaucoma	3.41e-05	0.00108	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—VEGFA—glaucoma	3.37e-05	0.00107	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—CDKN2B—glaucoma	3.36e-05	0.00107	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MMP9—glaucoma	3.33e-05	0.00106	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MMP9—glaucoma	3.33e-05	0.00106	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MMP9—glaucoma	3.32e-05	0.00105	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OPN4—glaucoma	3.32e-05	0.00105	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	3.29e-05	0.00104	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MMP2—glaucoma	3.28e-05	0.00104	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MMP2—glaucoma	3.28e-05	0.00104	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—VEGFA—glaucoma	3.26e-05	0.00103	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TNF—glaucoma	3.23e-05	0.00103	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—VEGFA—glaucoma	3.23e-05	0.00102	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CA1—glaucoma	3.21e-05	0.00102	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MMP2—glaucoma	3.16e-05	0.001	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MMP2—glaucoma	3.16e-05	0.001	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.13e-05	0.000994	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TNF—glaucoma	3.13e-05	0.000993	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MMP2—glaucoma	3.11e-05	0.000988	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CTSA—glaucoma	3.1e-05	0.000985	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—VEGFA—glaucoma	3.1e-05	0.000984	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—VEGFA—glaucoma	3.1e-05	0.000984	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	3.09e-05	0.000981	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—CYP1B1—glaucoma	3.06e-05	0.000971	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	3.02e-05	0.000958	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—VEGFA—glaucoma	2.99e-05	0.000949	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—VEGFA—glaucoma	2.99e-05	0.000949	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PTGFR—glaucoma	2.99e-05	0.000947	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—VEGFA—glaucoma	2.98e-05	0.000945	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—PAX6—glaucoma	2.96e-05	0.000938	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NR3C1—glaucoma	2.95e-05	0.000936	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—SMO—glaucoma	2.93e-05	0.000931	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CA2—glaucoma	2.93e-05	0.00093	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.93e-05	0.000929	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.92e-05	0.000926	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.87e-05	0.000909	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.87e-05	0.000909	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CA1—glaucoma	2.86e-05	0.000907	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LRP12—glaucoma	2.83e-05	0.000897	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TNF—glaucoma	2.79e-05	0.000885	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—C3—glaucoma	2.79e-05	0.000885	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CTSA—glaucoma	2.77e-05	0.000879	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CA5A—glaucoma	2.69e-05	0.000854	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NARFL—glaucoma	2.69e-05	0.000854	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MMP9—glaucoma	2.68e-05	0.000851	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—PAX6—glaucoma	2.64e-05	0.000837	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TXN—glaucoma	2.62e-05	0.000833	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CA2—glaucoma	2.62e-05	0.00083	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MMP9—glaucoma	2.57e-05	0.000814	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.56e-05	0.000811	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.56e-05	0.000811	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CA1—glaucoma	2.55e-05	0.00081	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TNF—glaucoma	2.55e-05	0.00081	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.54e-05	0.000806	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CTSA—glaucoma	2.47e-05	0.000785	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MMP9—glaucoma	2.46e-05	0.000782	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MMP9—glaucoma	2.46e-05	0.000782	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.45e-05	0.000776	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.44e-05	0.000773	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.41e-05	0.000766	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VEGFA—glaucoma	2.41e-05	0.000764	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CA1—glaucoma	2.38e-05	0.000755	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MMP9—glaucoma	2.38e-05	0.000754	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MMP9—glaucoma	2.38e-05	0.000754	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MMP9—glaucoma	2.34e-05	0.000743	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CA2—glaucoma	2.34e-05	0.000741	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CTSA—glaucoma	2.31e-05	0.000732	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VEGFA—glaucoma	2.3e-05	0.000731	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP2—glaucoma	2.22e-05	0.000705	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.22e-05	0.000704	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—glaucoma	2.21e-05	0.000702	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—glaucoma	2.21e-05	0.000702	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CA2—glaucoma	2.18e-05	0.000691	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—glaucoma	2.13e-05	0.000677	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—glaucoma	2.13e-05	0.000677	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—glaucoma	2.1e-05	0.000667	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.09e-05	0.000662	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TXN—glaucoma	2.07e-05	0.000655	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—glaucoma	2.06e-05	0.000655	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTT1—glaucoma	2.03e-05	0.000646	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—glaucoma	1.97e-05	0.000626	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OPN4—glaucoma	1.96e-05	0.000621	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.95e-05	0.000617	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—EDN1—glaucoma	1.93e-05	0.000614	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—glaucoma	1.9e-05	0.000602	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—glaucoma	1.9e-05	0.000602	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.88e-05	0.000598	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.87e-05	0.000593	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TXN—glaucoma	1.84e-05	0.000585	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.84e-05	0.000584	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—glaucoma	1.83e-05	0.00058	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—glaucoma	1.83e-05	0.00058	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HEYL—glaucoma	1.82e-05	0.000578	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTGFR—glaucoma	1.76e-05	0.00056	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—C3—glaucoma	1.69e-05	0.000536	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP1—glaucoma	1.68e-05	0.000534	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.68e-05	0.000533	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP9—glaucoma	1.67e-05	0.00053	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	1.67e-05	0.000529	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.67e-05	0.000529	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TXN—glaucoma	1.65e-05	0.000522	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ABCA1—glaucoma	1.62e-05	0.000514	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP1B1—glaucoma	1.62e-05	0.000514	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTT1—glaucoma	1.6e-05	0.000508	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TXN—glaucoma	1.53e-05	0.000487	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SMO—glaucoma	1.51e-05	0.000478	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP1—glaucoma	1.5e-05	0.000476	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—glaucoma	1.5e-05	0.000476	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTT1—glaucoma	1.43e-05	0.000453	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RPTOR—glaucoma	1.38e-05	0.000438	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NCK2—glaucoma	1.34e-05	0.000424	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CA1—glaucoma	1.31e-05	0.000417	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP2—glaucoma	1.3e-05	0.000413	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTM1—glaucoma	1.3e-05	0.000411	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.29e-05	0.00041	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—glaucoma	1.29e-05	0.000408	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP1B1—glaucoma	1.28e-05	0.000405	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCA1—glaucoma	1.28e-05	0.000405	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTT1—glaucoma	1.28e-05	0.000405	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CTSA—glaucoma	1.27e-05	0.000404	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CA2—glaucoma	1.2e-05	0.000382	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTT1—glaucoma	1.19e-05	0.000377	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP2—glaucoma	1.16e-05	0.000369	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.15e-05	0.000366	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—glaucoma	1.15e-05	0.000363	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCA1—glaucoma	1.14e-05	0.000361	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP1B1—glaucoma	1.14e-05	0.000361	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HDAC9—glaucoma	1.14e-05	0.000361	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.09e-05	0.000347	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—APOE—glaucoma	1.07e-05	0.000338	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CAV1—glaucoma	1.06e-05	0.000335	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTM1—glaucoma	1.02e-05	0.000324	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP1B1—glaucoma	1.02e-05	0.000323	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCA1—glaucoma	1.02e-05	0.000323	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EDN1—glaucoma	9.92e-06	0.000315	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—C3—glaucoma	9.55e-06	0.000303	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCA1—glaucoma	9.48e-06	0.000301	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1B1—glaucoma	9.48e-06	0.000301	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTM1—glaucoma	9.1e-06	0.000289	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—glaucoma	9.02e-06	0.000286	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SMO—glaucoma	8.89e-06	0.000282	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—C3—glaucoma	8.67e-06	0.000275	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TXN—glaucoma	8.47e-06	0.000269	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOE—glaucoma	8.39e-06	0.000266	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CAV1—glaucoma	8.32e-06	0.000264	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NTRK2—glaucoma	8.13e-06	0.000258	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTM1—glaucoma	8.13e-06	0.000258	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—glaucoma	8.04e-06	0.000255	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—glaucoma	7.99e-06	0.000253	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTM1—glaucoma	7.58e-06	0.00024	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOE—glaucoma	7.49e-06	0.000238	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CAV1—glaucoma	7.42e-06	0.000235	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—glaucoma	7.31e-06	0.000232	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—glaucoma	7.18e-06	0.000228	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NGFR—glaucoma	6.98e-06	0.000221	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—glaucoma	6.7e-06	0.000212	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOE—glaucoma	6.69e-06	0.000212	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NTRK1—glaucoma	6.63e-06	0.00021	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAV1—glaucoma	6.63e-06	0.00021	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTT1—glaucoma	6.57e-06	0.000208	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—glaucoma	6.29e-06	0.0002	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOE—glaucoma	6.23e-06	0.000198	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAV1—glaucoma	6.18e-06	0.000196	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN2B—glaucoma	6.11e-06	0.000194	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDN1—glaucoma	5.86e-06	0.000186	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—glaucoma	5.75e-06	0.000182	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—glaucoma	5.61e-06	0.000178	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NGF—glaucoma	5.39e-06	0.000171	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCA1—glaucoma	5.23e-06	0.000166	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1B1—glaucoma	5.23e-06	0.000166	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—glaucoma	5.13e-06	0.000163	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—C3—glaucoma	5.12e-06	0.000162	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—glaucoma	5.01e-06	0.000159	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOE—glaucoma	4.77e-06	0.000151	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CAV1—glaucoma	4.72e-06	0.00015	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—glaucoma	4.67e-06	0.000148	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—glaucoma	4.58e-06	0.000145	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FN1—glaucoma	4.5e-06	0.000143	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BAD—glaucoma	4.44e-06	0.000141	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—glaucoma	4.27e-06	0.000136	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTM1—glaucoma	4.18e-06	0.000133	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—glaucoma	3.7e-06	0.000117	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—glaucoma	3.57e-06	0.000113	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOE—glaucoma	3.44e-06	0.000109	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAV1—glaucoma	3.41e-06	0.000108	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1B—glaucoma	3.09e-06	9.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—glaucoma	2.87e-06	9.09e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—glaucoma	2.58e-06	8.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—glaucoma	2.57e-06	8.17e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—glaucoma	2.36e-06	7.49e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—glaucoma	1.94e-06	6.17e-05	CbGpPWpGaD
